Literature DB >> 16408854

Laboratory diagnosis of leptospirosis.

Z Cermáková1, L Plísková, O Rysková.   

Abstract

Percentage of serological positivity examined in 4205 blood sera by serological method microscopic agglutination test (MAT) on the hinterland territory of our laboratory (East Bohemia; 1999-2003) was 0.38-4.7 %. By the PCR method for detection of DNA of pathogenic leptospires (L. interrogans, L. borgpetersenii and L. kirschneri) from 57 samples of different biological materials from patients with fever of unknown etiology positive results were obtained in 4 specimens (7 %; 3 samples of urine and 1 sample of blood). This method was shown to distinguish between pathogenic and nonpathogenic strains and can detect 2.5-10 cells per mL of biological material. As an important presumption of successful detection of pathogenic leptospires a correct collecting of blood, urine samples or liquor is required before starting antibody therapy. The PCR method possesses a clear advantage over other methods, such as MAT, which relies on the detection of antibodies the presence of which cannot be detected until days after infection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16408854     DOI: 10.1007/bf02931416

Source DB:  PubMed          Journal:  Folia Microbiol (Praha)        ISSN: 0015-5632            Impact factor:   2.099


  10 in total

1.  Clinical presentation of leptospirosis: a retrospective study of 34 patients admitted to a single institution in metropolitan France.

Authors:  S Jauréguiberry; M Roussel; G Brinchault-Rabin; A Gacouin; A Le Meur; C Arvieux; C Michelet; P Tattevin
Journal:  Clin Microbiol Infect       Date:  2005-05       Impact factor: 8.067

2.  Differentiation of pathogenic and non-pathogenic leptospires by means of the polymerase chain reaction.

Authors:  A E Parma; A Seijo; P M Lucchesi; B Deodato; M E Sanz
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1997 Jul-Aug       Impact factor: 1.846

3.  Detection of leptospires in urine by PCR for early diagnosis of leptospirosis.

Authors:  A E Bal; C Gravekamp; R A Hartskeerl; J De Meza-Brewster; H Korver; W J Terpstra
Journal:  J Clin Microbiol       Date:  1994-08       Impact factor: 5.948

4.  Following the course of human leptospirosis: evidence of a critical threshold for the vital prognosis using a quantitative PCR assay.

Authors:  J Truccolo; O Serais; F Merien; P Perolat
Journal:  FEMS Microbiol Lett       Date:  2001-11-13       Impact factor: 2.742

5.  Detection of seven species of pathogenic leptospires by PCR using two sets of primers.

Authors:  C Gravekamp; H Van de Kemp; M Franzen; D Carrington; G J Schoone; G J Van Eys; C O Everard; R A Hartskeerl; W J Terpstra
Journal:  J Gen Microbiol       Date:  1993-08

Review 6.  Ocular leptospirosis.

Authors:  S R Rathinam
Journal:  Curr Opin Ophthalmol       Date:  2002-12       Impact factor: 3.761

7.  Polymerase chain reaction for detection of Leptospira spp. in clinical samples.

Authors:  F Mérien; P Amouriaux; P Perolat; G Baranton; I Saint Girons
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

8.  Epidemic leptospirosis associated with pulmonary hemorrhage-Nicaragua, 1995.

Authors:  R T Trevejo; J G Rigau-Pérez; D A Ashford; E M McClure; C Jarquín-González; J J Amador; J O de los Reyes; A Gonzalez; S R Zaki; W J Shieh; R G McLean; R S Nasci; R S Weyant; C A Bolin; S L Bragg; B A Perkins; R A Spiegel
Journal:  J Infect Dis       Date:  1998-11       Impact factor: 5.226

9.  Leptospirosis in "Eco-Challenge" athletes, Malaysian Borneo, 2000.

Authors:  James Sejvar; Elizabeth Bancroft; Kevin Winthrop; Julie Bettinger; Mary Bajani; Sandra Bragg; Kathleen Shutt; Robyn Kaiser; Nina Marano; Tanja Popovic; Jordan Tappero; David Ashford; Laurene Mascola; Duc Vugia; Bradley Perkins; Nancy Rosenstein
Journal:  Emerg Infect Dis       Date:  2003-06       Impact factor: 6.883

10.  A quantitative PCR (TaqMan) assay for pathogenic Leptospira spp.

Authors:  Lee D Smythe; Ina L Smith; Greg A Smith; Michael F Dohnt; Meegan L Symonds; Leonie J Barnett; David B McKay
Journal:  BMC Infect Dis       Date:  2002-07-08       Impact factor: 3.090

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.